- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
면역 체계에 대한 임상 시험
총 190131 건
-
Kirby InstitutePfizer; ViiV Healthcare완전한에이즈스페인, 호주, 아일랜드, 멕시코, 독일, 아르헨티나, 캐나다, 칠레, 프랑스, 일본, 폴란드, 태국, 영국
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)완전한
-
Association Pour la Recherche en Infectiologie알려지지 않은
-
Assistance Publique Hopitaux De Marseille알려지지 않은
-
National Institute of Allergy and Infectious Diseases...빼는
-
Centers for Disease Control and PreventionKenya Medical Research Institute; United States President's Emergency Plan for AIDS Relief완전한
-
Centers for Disease Control and Prevention알려지지 않은
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID); Fogarty International Center...완전한
-
Moi UniversityCenters for Disease Control and Prevention알려지지 않은
-
University of Wisconsin, MilwaukeeEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of Pennsylvania 그리고 다른 협력자들완전한
-
University of WashingtonMerck Sharp & Dohme LLC완전한
-
The HIV Netherlands Australia Thailand Research...amfAR, The Foundation for AIDS Research; National Health Security Office, Thailand; The Thai...완전한
-
Canadian Immunodeficiency Research Collaborative완전한
-
University of California, San FranciscoKenya Medical Research Institute; Organic Health Response; Microclinic International완전한
-
The Hospital for Sick Children완전한
-
Liverpool School of Tropical MedicineLondon School of Hygiene and Tropical Medicine; Kamuzu University of Health Sciences; Ministry...완전한
-
University of North Carolina, Chapel HillMerck Sharp & Dohme LLC빼는
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of North Carolina완전한
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)완전한
-
FHI 360Gilead Sciences; University of North Carolina, Chapel Hill; Family Health Options Kenya; Institute... 그리고 다른 협력자들빼는
-
Tibotec Pharmaceuticals, Ireland완전한TMC114-C211: 항레트로바이러스 약물 치료를 받은 적이 없는 HIV-1 감염 환자에서 리토나비르("TMC114/r")와 함께 프로테아제 억제제 TMC114를 조사하는 시험.에이즈미국, 프랑스, 영국, 독일, 대만, 스페인, 벨기에, 칠레, 코스타리카, 파나마, 남아프리카, 캐나다, 그리스, 싱가포르, 아르헨티나, 멕시코, 푸에르토 리코, 오스트리아, 러시아 연방, 태국, 호주, 덴마크, 스위스, 과테말라, 말레이시아
-
California Pacific Medical Center Research InstituteNational Institutes of Health (NIH); University of California, San Francisco; San Francisco...완전한
-
University of California, San FranciscoGenentech, Inc.빼는
-
Duke UniversityGlaxoSmithKline완전한
-
St. Luke's-Roosevelt Hospital CenterGilead Sciences완전한
-
Creighton UniversityRoche Pharma AG완전한
-
ViiV HealthcarePfizer완전한
-
Bristol-Myers SquibbMerck Sharp & Dohme LLC종료됨
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada완전한
-
Tibotec Pharmaceuticals, Ireland완전한
-
Circassia LimitedAdiga Life Sciences, Inc.완전한
-
Bristol-Myers SquibbMerck Sharp & Dohme LLC; Dohme Australia완전한
-
Circassia LimitedAdiga Life Sciences, Inc.완전한